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Abstract
Objective The aim of this study was to clarify
the characteristic findings in myopic choroidal
neovascularization (CNV) and the relationship
with lacquer crack (LC).
Methods In all, 66 consecutive myopic CNV
patients treated with photodynamic therapy
and/or intravitreal anti-vascular endothelial
growth factor injection in one eye were reviewed.
Data from fluorescein angiography (FA) and
indocyanine green angiography (ICGA),
obtained simultaneously using the Heidelberg
retina angiograph 2 (HRA2), were analyzed.
Results LCs were associated with a relatively
large extent (Z3000 lm) of peripapillary
choroidal atrophy and a dark rim, the
proliferation of retinal pigment epithelial cells
surrounding the neovascular membrane was
accompanied by a small extent. Myopic CNV
usually developed in the LC area surrounded
by tiny crack fragments. In all, 35 patients with
LCs received FA and ICGA at least twice
during follow-up. LC progression was
observed in nine (25.7%) treated eyes and
six (23.1%) non-CNV fellow eyes. Crack
fragments progressed in three distinct forms
such as elongation, branching, or bridging
pattern. Newly diagnosed myopic CNV was
reported in 18 treated eyes and 3 fellow eyes.
Progression of LCs and development of CNV
occurred simultaneously in eight eyes. By
multivariate Cox’s regression, a statistically
significant association was observed between
recurrence of myopic CNV and the absence of
a dark rim on ICGA.
Conclusions The HRA2 instrument affords
detailed high-resolution images of FA and
ICGA. Notably, recurrence of myopic CNV
developed in areas surrounded by new small
crack fragments and LCs are considered to be
important in the development of myopic CNV.
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Introduction
Pathological myopia is the leading cause of
severe visual loss in many countries.1,2 High
myopia is especially common in Asian
populations, with rates of 9–21%,3,4 compared
with 2–4% in Caucasians.5–7
The pathogenesis of high myopia is
associated with progressive and excessive
elongation of the eyeball which predisposes to
various degenerative changes involving the
sclera, choroid, and retina.8,9 Myopic choroidal
neovascularization (CNV), the vision-
threatening complication of myopia,10,11
develops in 5–11% of patients with high
myopia.8,12,13
Indocyanine green angiography (ICGA) can
provide valuable information on choroidal
vessels because of its longer wavelength
fluorescence with limited diffusion within the
choriocapillaries compared with fluorescein
angiography (FA).14–16 Many characteristic
findings of myopic CNV are observed using
ICGA such as lacquer cracks (LCs),
peripapillary choroidal atrophy, any dark rim,
and late-phase hyperfluorescence. In particular,
LCs are considered important in the
development of the condition,13,17,18 but the
associated mechanism remains unclear so far.
The Heidelberg retina angiograph 2 (HRA2;
Heidelberg Engineering, Heidelberg, Germany),
a confocal scanning system, can yield detailed
images and perform FA and ICGA simultaneously
allowing comparison of images obtained at the
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same point of the retina. However, to the best of our
knowledge, few reports on the use of this technique in the
assessment of myopic CNV patients have appeared.
The purpose of this study was to identify characteristic
findings of myopic CNV, especially LC and to describe
factors prognostic for recurrence of the condition.
Materials and methods
Subjects
We retrospectively reviewed the medical records of
66 consecutive myopic CNV patients who received
photodynamic therapy (PDT) and/or intravitreal
ranibizumab or bevacizumab injection between
1 March 2005 and 31 May 2008 at the Department of
Ophthalmology, Yonsei University College of Medicine,
Seoul, Korea. This study was conducted in accordance
with the principles of the Declaration of Helsinki and
carried out with the approval of our Institutional Review
Board. Potential risks and benefits were discussed with
all patients before they received treatment and each
patient read and signed an informed consent form.
Patients were included if they met all of the following
criteria: (1) previous treatment with PDT and/or
intravitreal anti-vascular endothelial growth factor
(anti-VEGF) antibody (ranibizumab or bevacizumab) for
myopic CNV in one eye, defined as the presence of active
leakage from the CNV on FA, with a refractive error
exceeding 6.0 diopters (spherical equivalent) or an axial
length of Z26.5 mm; and (2) subfoveal, juxtafoveal, or
extrafoveal myopic CNV. Exclusion criteria included (1) a
history of laser photocoagulation, radiation, subtenon
injection of triamcinolone acetonide, or vitreoretinal
surgery on the study eye; (2) absence of FA and ICGA
data at baseline; and (3) the presence of diabetic
retinopathy, branch retinal vein occlusion, or other
vascular diseases that might affect FA and ICGA.
Examination
Initial evaluation included refraction measurement,
fundus photography, FA, ICGA, and optical coherence
tomography (OCT). FA and ICGA were performed
simultaneously using a confocal laser scanning system
(HRA2). The presence and location of each LC were
identified in the late phase of ICGA. The presence of LC
and progression of LC with development of new CNV
during follow-up period was also evaluated in the
non-CNV fellow eyes. A dark rim was defined as a
circular background hypofluorescence surrounding the
neovascular membrane, and was detected in the early
phase of ICGA. Late-phase ICGA hyperfluorescence was
also noted. The extent of peripapillary choroidal atrophy
was measured as the greatest linear dimension (GLD) of
the hypofluorescent area around the disc, as seen in the
late phase of ICGA. All measurements were taken by a
physician masked to patient details.
Treatment
Patients who received standard PDT were treated using
the protocol described in the Verteporfin in
Photodynamic Therapy study. In brief, spot size was
determined after measuring the GLD of the entire CNV
lesion by FA. An additional 1000 mm was added to the
GLD figure to provide a 500-mm treatment rim around
the lesion. The dose and timing of verteporfin infusion
were 6 mg/m2 body surface area over a 10-min period,
and laser light (50 J/cm2 for 83 s) was delivered at 15 min
after the start of infusion.
Intravitreal anti-VEGF injections delivered 1.25 mg of
bevacizumab or 0.5 mg of ranibizumab. Drugs were
injected into the vitreous cavity through the superior
sclera using a 30-gauge needle, at a position 4 mm
posterior to the corneal limbus.
Follow-up visits were arranged at 1 week and at
1 month after the initial treatment, then scheduled at
3-month interval; work-up at these visits included FA
and OCT. The treatment was repeated when recurrence
of myopic CNV was detected. Recurrence was defined as
the CNV leakage observed by FA or subretinal fluid
visible on OCT.
Statistical analysis
To investigate factors contributing to specific findings on
ICGA and to compare the morphological appearance of
LCs, Student’s t-tests for analysis of continuous variables
and w2-tests exploring categorical variables were used.
Multiple logistic regression and Cox’s regression analysis
were used to elucidate the independent influence of each
potential factor on presence of LCs and recurrence of
myopic CNV, respectively. Statistical analysis was
performed using SPSS 15.0 for Windows (SPSS Inc.,
Chicago, IL, USA) and SAS version 9.13 (SAS, Cary, NC,
USA). Mauchly’s test of sphericity and Kolmogorov–
Smirnov analysis were used to confirm statistical validity.
Results
Baseline patient characteristics
The characteristics of the 66 patients (66 eyes) with
treatment of myopic CNV in one eye are summarized in
Table 1. In all, 12 men (18.2%) and 54 women (81.8%)
were included in the study. An LC was detected in
37 eyes, of which 22 showed LCs of linear-type and
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15 stellate-type LCs. A dark rim was found in 33 eyes.
Late-phase hyperfluorescence was observed in 12 eyes.
In the non-CNV fellow eyes, there was an LC of 26 eyes,
of which 17 were LCs of linear-type, and 9 were
stellate-type.
Relationship between features on ICGA
The presence of an LC was associated with a relatively
large degree (Z3000mm) of peripapillary choroidal
atrophy (Po0.001). However, myopic CNV with a dark
rim showed a small extent (o3000 mm) of such atrophy
(P¼ 0.003; Table 2). Figure 1 shows instances of myopic
CNV without an LC but with a dark rim around the
neovascular membrane, as seen on early phase ICGA.
The location of myopic CNV
In patients with linear-type LCs, the location of myopic
CNV was either within the area of the LC (11 eyes, 50.0%)
or at the tip of the LC (11 eyes, 50.0%). However, CNV
always occurred in the LC, the location nearest to the
fovea and, especially, in a region surrounded by very tiny
crack fragments. Therefore, the spatial relationship
between LC and fovea was important to detect the site of
myopic CNV (Figure 2). In patients with stellate-type
LCs, myopic CNV was located near the center of the
LC (14 eyes, 93.3%) or at the tip of the LC (1 eye, 6.7%).
The center of the LC usually did not coincide with
the fovea, and CNV tended to occur in the inner corner
of the radiating arm nearest to the fovea. Figure 3
shows instances of myopic CNV associated with stellate-
type LCs.
Myopic CNV did not develop from the precise position
of the LC per se. An LC consisted of a collection of small
dot-shaped crack fragments and CNV was located in the
area surrounded by these fragments, as shown in Figures
2 and 3. Small LC fragments were clearly noted in 25 eyes
and the location of CNV corresponded with the region
surrounded by such tiny dot-shaped crack fragments
in 23 eyes.
Subgroup analysis according to presence of LC
There was no significant difference in age, refractive
error, visual acuity, CNV size, extent of peripapillary
choroidal atrophy, presence of a dark rim, or location of
CNV between the patients with two types of LCs. Table 3
illustrates possible clinical factors affecting the
occurrence of an LC. Older age, higher refractive error,
absence of a dark rim, and greater extent of peripapillary
choroidal atrophy were associated with the presence of
an LC. After multivariate logistic regression analysis,
only the area of peripapillary choroidal atrophy showed
a significant correlation with occurrence of an LC
(P¼ 0.02).
Progression of LC
In all, 35 treated eyes and 26 non-CNV fellow eyes with
LCs were examined by FA and ICGA more than twice
during the follow-up period and selected for analysis of
LC progression. The mean time interval between the
initial and final ICGA examinations was 17.4±10.6
months. LC progression was observed in nine (25.7%)
treated eyes and six (23.1%) non-CNV fellow eyes.
Progression of LC and recurrence of myopic CNV
occurred simultaneously in five treated eyes, and new
CNV with progression of LC developed in three
non-CNV fellow eyes. In the other four treated and three
fellow eyes, LC progression was noted, but was not
accompanied by outbreak of CNV.
LC progression was associated with the production of
increasing amounts of small crack fragments. These
fragments appeared slowly, in three different patterns,
arising from the tip of an existing LC (elongation, 66.7%),
Table 2 Comparison of clinical features between subgroups
based on the size of peripapillary choroidal atrophy
o3000mm
(n¼ 33)
Z3000mm
(n¼ 33)
P-value
Presence of lacquer
crack (%)
4/33 (12.1) 29/33 (87.9) o0.001
Presence of dark rim (%) 23/33 (69.7) 10/33 (30.3) 0.003
The w2-test was used to compare nominal variables.
Table 1 Baseline characteristics of patients (n¼ 66)
Characteristics
Age 46.9±12.1
Male/total (%) 12/66 (18.2)
Pseudophakic/total (%) 5/66 (7.6)
Refractive error (diopters) 10.6±5.4
GLD of CNV (mm) 1720±559
Location of CNV
Subfovea (%) 30 (45.4)
Juxtafovea (%) 30 (45.4)
Extrafovea (%) 6 (9.1)
Treatment of CNV
PDT only (%) 22 (33.3)
PDTþanti-VEGF injection (%) 18 (27.3)
Anti-VEGF injection only (%) 26 (39.4)
Baseline corrected VA (logMAR) 0.57±0.36
Abbreviations: anti-VEGF, anti-vascular endothelial growth factor;
CNV, choroidal neovascularization; GLD, greatest linear dimension;
PDT, photodynamic therapy; VA, visual acuity.
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the side of an existing LC (branching, 26.7%), or remote
from an existing LC but later connecting with the LC
(bridging, 46.7%; Figures 4 and 5). The progression
pattern often appeared as a mixture of these three types.
LCs of fellow eyes with no treatment showed 50%
elongation, 33.3% branching, and 50% bridging pattern.
Conversion of a linear-type LC to the stellate type
occurred in one patient (Figure 4).
The relationship between LC and recurrence of myopic
CNV
The development of myopic CNV was detected in 18
treated eyes and 3 fellow eyes. Myopic CNV recurred at
the same location as that of primary CNV in 7 eyes and at
a different location in 11. In all seven eyes in which
recurrence was noted in the location of the primary CNV,
LCs showed no definite progression. Among the 11 eyes
in which recurrence was at different locations, 5 showed
progression of LCs, as shown in Figure 6. In six eyes, all
with stellate-type LCs, changes in or progression of LCs
could not be confirmed. In these cases, small LC
fragments were difficult to observe because multiple
choroidal atrophy was present and ICGA data were thus
of poor quality. The fact that ICGA examinations were
conducted at irregular intervals made it difficult to
precisely define LC progression.
Three non-CNV fellow eyes showed new development
of myopic CNV, with progression of LCs. Two patients
complained of metamorphopsia before recurrence of
myopic CNV. There was no definite evidence of myopic
CNV by fundus photography, FA or ICGA at initial
examination, but the condition developed several
months later.
Factors predicting recurrence of myopic CNV
The mean follow-up period for myopic CNV patients
was 22.7±10.1 months. The follow-up period for patients
treated by anti-VEGF injection alone was only 15.9
months, thus shorter than that for other patients
receiving PDT only, or the combination treatment who
experienced follow-up periods of 27.5 or 26.3 months.
The overall recurrence rate of myopic CNV was 36.4%
(24 eyes). In patients treated with PDT only, the overall
recurrence rate was 54.5% (12 eyes), being 50.0% (9 eyes)
and 11.5% (3 eyes) in patients treated with combination
therapy and anti-VEGF injection, respectively.
Table 4 shows variables significant in the prediction of
myopic CNV recurrence, as identified by Cox’s
regression analysis. Only the absence of a dark rim
showed a significant correlation with recurrence of
myopic CNV (odds ratio: 8.05; 95% confidence interval:
1.65–39.19; P¼ 0.01).
Figure 1 Patients with myopic CNV but without LCs. FA shows fluorescein dye leakage from myopic CNV (white arrow; a and d).
Early phase ICGA indicates a dark rim (black arrow; b and e) and late phase ICGA shows a residual dark rim around the neovascular
membrane (white arrow; c and f).
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Discussion
The characteristic findings of myopic CNV on ICGA,
including LC, dark rim, and peripapillary choroidal
atrophy, have been used for diagnosis of the condition,
and in attempts to understand the mechanism of CNV
development. In particular, LCs are formed by ruptures
in Bruch’s membrane, in which small hemorrhages may
develop, and often accompany myopic CNV. Recently,
LCs have been considered to induce the development of
myopic CNV.13,17,18 In this study, we have shown a strong
correlation between presence of LC and a relatively large
(Z3000 mm) extent of peripapillary choroidal atrophy.
Few reports have addressed the mechanism of
peripapillary choroidal atrophy. Yasuzumi et al19
suggested that a peripapillary myopic crescent might
develop as a result of mechanical stretching. If both
peripapillary choroidal atrophy and LCs are attributable
to stretching of RPE/choroidal tissue induced by myopic
axial elongation, these conditions should be of similar
prevalence in patients with degenerative myopic fundi.
LCs can be classified in many ways, but are usually
divided into two major morphological types: linear and
stellate.18,20–22 In this study, linear-type LC was evident in
22 eyes, and stellate-type in 15 eyes. Conversion of an LC
from the linear type to the stellate type occurred in one
patient who had undergone previous PDT treatment,
suggesting that PDT may affect the normal growth or
progression of an LC.
Among 37 eyes with myopic CNV associated with LCs,
CNV had developed along the LCs in 36. In both LC
types, each LC consisted of a collection of small dot-
shaped crack fragments. In linear-type LC, the location of
CNV was in the LC region nearest to the fovea. More
precisely, the area of origin was surrounded by small
fragments of the LC in a region into which the LC did not
extend. The occurred site of CNV in the center or at the
tip of linear-type LC depended on the location of LC with
respect to the fovea. When the LC lay over the fovea,
CNV usually developed in the center. However, CNV
occurred at the tip of the LC nearest to the fovea when
the LC lay outside of the fovea. With stellate-type LCs,
Figure 2 Patients with myopic CNV associated with linear-type LCs. FA shows fluorescein dye leakage (white circle) from myopic
CNV (a and c). Late phase ICGA indicates small fragments of LCs (white circle; b and d). The area surrounded by these small crack
fragments is the location of myopic CNV. The white circle indicates an identical region on both FA and ICGA.
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the location of CNV was in the inner corner of the
radiating arm nearest to the fovea. Detailed imaging and
analysis of LCs were possible in this study because of the
high sensitivity of the confocal ICGA system.
We categorized the LC progression into three different
forms: elongation, branching, and bridging pattern. Most
LCs progressed by elongation, but development of
myopic CNV was associated with only the branching
(57.1%) and bridging (42.9%) patterns. It is possible that
some bridging patterns were scored as elongation
patterns because of the relatively long intervals between
ICGA examinations. Also, some irregular progression
patterns could not be categorized using any of the three
pattern types. Further studies using regular ICGA
examination at short time intervals would be useful to
increase our understanding of LC progression.
Figure 3 Patients with myopic CNV associated with stellate-type LCs. FA shows fluorescein dye leakage (white circle) from myopic
CNV near the fovea (white star) in two patients (a and c). Myopic CNV is located in the inner corner of the arm radiating from the LC
nearest the fovea and small linear-type LCs (black arrows) surrounding CNV are seen close to the fovea (b). Myopic CNV occurred at
the tip of a radiating arm near the fovea, whereas a diffuse LC is located at the inferotemporal macula (d).
Table 3 Logistic regression analysis for presence of lacquer crack
Variables Univariate Multivariate
Regression coefficienta (SE) P-value Regression coefficienta (SE) P-value
Age 0.202 (0.050) o0.001 0.260 (0.154) 0.09
Gender (female) 0.711 (0.648) 0.27
Refractive error (diopters) 0.405 (0.120) o0.001 0.471 (0.462) 0.31
GLD of CNV (mm) 0.450 (0.047) 0.34
Presence of dark rim 1.699 (0.544) 0.002 0.924 (0.878) 0.62
Size of peripapillary choroidal atrophy (mm) 0.520 (0.132) o0.001 0.732 (0.329) 0.02
Abbreviations: CNV, choroidal neovascularization; GLD, greatest linear dimension.
aThe standardized regression coefficient (b) was derived for standardization between variables.
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Figure 4 Patients showing LC progression. A linear-type LC is shown on late-phase ICGA (a). At 26 months later, a new small crack,
showing a bridging pattern, developed remote from the previous LC (white arrow; b). At 6 months later, another new crack (black
arrow) bridged over to the first LC, progressing toward the crack that developed at 26 months (white arrow; c). A linear LC is
horizontally located, from the disc to the fovea (d). This LC became extended from a tip with an elongation pattern (white arrow; e).
A new crack appeared, remote from the pre-existing LC in a bridging pattern (black arrow; f).
Figure 5 Patients showing LC progression. A stellate-type LC is evident near the disc, extending to the fovea, and small crack
fragment in a bridging pattern lies separate from the main LC (white arrow; a). At 21 months later, newly developed LCs (black
arrows) bridged the pre-existing LCs (white arrow; d). No definite LC was noted at first (b). At 13 months later, multiple new crack
fragments appeared (white arrows; e). Irregular, multiple LCs lie near the disc (c). At 18 months later, new crack fragments in an
elongation pattern are evident (white arrows; f).
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Progression of LC was also observed on the
development of myopic CNV. Five treated eyes showed
LC progression and recurrence of CNV at newly
developed LCs. Progression of LCs and development
of new myopic CNV were detected simultaneously in
non-CNV fellow eyes. Outbreak of CNV was associated
with recently formed LCs. Axer-Siegel et al17 reported
that extension of LCs accompanied newly developed
myopic CNV and that vigorous healing of new LCs
might have contributed to the development of CNV. In
this study, LCs progressed with an increase in the
number of small crack fragments and myopic CNV
was usually located in an area surrounded by these
fragments. A possible explanation is that the area
surrounded by new small crack fragments, as well as the
LC per se, is engaged in a vigorous healing process
resulting in initiation of myopic CNV.
Multiple Cox’s regression analysis showed that the
dark rim was the only significant factor predicting
non-recurrence of myopic CNV. Histopathologically, the
rim reflects proliferation of RPE cells surrounding CNV
in the subretinal space.23 The RPE cells block
fluorescence of the choroid, and may prevent active
leakage from myopic CNV. The dark rim, composed of
multilayered proliferating RPE cells surrounding the
neovascular membrane, may have a strong regenerative
Figure 6 Patients showing LC progression and recurring myopic CNV. FA shows fluorescein dye leakage (white circle) from myopic
CNV (a) and late phase ICGA demonstrates an LC surrounding CNV (d). PDT was performed twice and myopic CNV recurred at
9 months later. Fluorescein dye leakages are apparent, from prior and newly developed CNV (b). ICGA reveals an area surrounded by
new small crack fragments in a branching pattern (black arrow) that corresponds to CNV (white circle; e). New crack fragments,
showing an elongation pattern, appeared at 6 months later (white arrows; c). These cracks progressed slowly in a branching pattern at
19 months later (white arrows; f).
Table 4 Cox’s regression analysis model for prognostic factors in recurrence in myopic CNV
Variables Univariate Multivariate
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Age 1.02 (0.99–1.05) 0.27 0.99 (0.97–1.03) 0.92
Gender (female) 1.60 (0.47–5.52) 0.45 0.39 (0.08–1.92) 0.39
Refractive error (diopters) 1.01 (0.94–1.08) 0.85
GLD of CNV (mm) 1.00 (1.00–1.01) 0.54
Presence of lacquer crack 1.08 (0.45–2.58) 0.87
Absence of dark rim 4.86 (1.42–16.66) 0.01 8.05 (1.65–39.19) 0.01
Treatment of PDT 0.95 (0.27–3.36) 0.94
Peripapillary choroidal atrophy size (mm) 1.00 (1.00–1.00) 0.42
Abbreviations: CI, confidence interval; CNV, choroidal neovascularization; GLD, greatest linear dimension; PDT, photodynamic therapy.
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potential. Thus, patients showing a dark rim may benefit
more from treatments such as PDT or anti-VEGF
injections than patients without such a rim. Yoshida
et al24 reported that younger myopic CNV patients
(r40 years of age) retained relatively good visual acuity
without any treatment. However, the age of the patient
was not associated with recurrence of myopic CNV in
this study.
All patients enrolled in our study had received either
PDT and/or anti-VEGF injections to treat myopic CNV in
one eye. Thus, LC progression and any relationship
thereof with recurrence of myopic CNV might have been
affected by these previous treatments. However,
non-CNV fellow eyes without myopic CNV were also
included in the analysis, and both the pattern of LC
progression and the occurrence of myopic CNV were
similar.
This study has some limitations, especially in that our
data do not precisely reflect the natural course of LC
development or recurrence of CNV. Follow-up periods
differed between different treatment groups. Eyes
receiving PDT or the combined treatment were
followed-up for a longer time than were eyes treated by
anti-VEGF injection only, because PDT had been
performed prior to the more recently available anti-VEGF
injection treatment. However, the use of PDT did not
influence the recurrence rate of myopic CNV after
adjustment of variables to remove covariate bias.
The detailed relationship between LCs and
development of myopic CNV, using HRA2 has been
described. The results of this study would contribute to
an understanding of the pathogenesis and prognosis of
myopic CNV, aspects of the condition poorly understood
to date.
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Summary
What was known before
K The characteristic findings of myopic choroidal
neovascularization (CNV) on indocyanine green
angiography (ICGA), including lacquer crack (LC), dark
rim, and peripapillary choroidal atrophy have been used
for the diagnosis of this condition and in attempts to
understand the mechanism. In particular, LCs are formed
by ruptures in Bruch’s membrane and often accompany
myopic CNV. Recently, LCs have been considered to
induce the development of myopic CNV.
What this study adds
K In this paper, we retrospectively reviewed myopic CNV
patients to understand the relationship between lacquer
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